Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05986240 |
|
Recruitment Status :
Recruiting
First Posted : August 14, 2023
Last Update Posted : May 9, 2024
|
Sponsor:
Montefiore Medical Center
Collaborators:
M.D. Anderson Cancer Center
Flamingo Therapeutics NV
Information provided by (Responsible Party):
Montefiore Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | October 2025 |
| Estimated Study Completion Date : | July 2028 |